Meg Doherty
@mdoherty_hiv
Director, Global HIV, Hepatitis, STI Programmes at WHO. Infectious Disease Specialist and Epidemiologist. Mother & humanitarian. Opinions/tweets are my own
#GileadNews: Today, we received positive opinions from the #CHMP for our long-acting HIV prevention medication. If approved, it could be an important step toward expanding #HIV prevention options in Europe and beyond: gilead.inc/3ILympx
Hepatitis takes over 1M lives each year. In a new @_UNChronicle piece, CGHE Director Dr. John Ward urges global action to expand HepB birth dose and HepC treatment. This #WorldHepatitisDay, stand for elimination. Read more: buff.ly/opSqOz2 #HealthForAll #HepElimination
Deeply shocked and saddened by the passing of our dear friend, colleague and @WHO Envoy David Nabarro. David was a great champion of global health and health equity, and a wise, generous mentor to countless individuals. His work touched and impacted so many lives across the…
Congratulations to Cambodia for becoming the second country in the Asia Pacific to offer long-acting PrEP! Read the testimonies of the first clients to begin long-acting injectable Cabotegravir in Cambodia:
🇷🇼 "Bridging Health Gaps in #Rwanda: a Community-Centred Response to #HIV and #HarmReduction" 🆕 @MedsPatentPool feature on @HDIRwanda, toured by media as part of an #IAS2025 site visit: medicinespatentpool.org/story-post/bri…
Les jeunes femmes en Afrique subsaharienne sont trois fois plus exposées au VIH que les jeunes hommes. Le lenacapavir peut changer la donne, mais seulement si nous garantissons un accès rapide, abordable et équitable. En savoir plus : unitaid.org/fr/news-blog/l…
I applaud the introduction of the #HIVMedicationAct. Expanding #PrEP access via @PEPFAR is not just smart policy – it is a moral imperative. Congress must deliver on the promise of HIV prevention.
📸 CGHE’s 2025 Elimination in Action Photo Contest is open! 📸 Submit images showing the fight to eliminate viral hepatitis—real work, real people, real impact. Cash prizes: $150–$1,000 Open to all 18+ Enter now: buff.ly/M7gxzY9 #HepElimination #GlobalHealth
🎥 #IAS2025 may be over, but you can watch over 500 past conference sessions from #AIDS2022, #IAS2023, #AIDS2024 and #HIVR4P2024 on #IASPlus for free! 🔎 Search sessions by topic, speaker and more: plus.iasociety.org/search/resourc…
We're #hiring! Seeking an an accomplished leader for the role of Deputy Executive Director: Operations. ⏰ Deadline to apply is 11 August. Find out more and the full job description ⤵️ frontlineaids.peoplehr.net/Pages/JobBoard…
Fantastic news by European Medicines Agency, they approved @GileadSciences' #lenacapavir PrEP for #EU market and also for non-EU countries (‘EU-Medicines for all’ (EU-M4all) programme) ema.europa.eu/en/news/new-in… @DrTedros @gabbystern @HIVpxresearch @JeremyFarrar @HIVpxresearch
It’s not enough for #HIV prevention drugs to be available; they must be truly accessible—affordable, stigma-free, and within reach for everyone who needs them. #EndAHD @WHO @KenlySikwese afrocab.org
In a new feature story out of #IAS2025, @aidsmap explores the question, "Does six-monthly PrEP have a future following the collapse of global #HIV funding?" aidsmap.com/news/jul-2025/…
#WorldHepatitisDay is just three days away! Join the global movement to raise awareness about hepatitis. Whether it’s by: 📲 Sharing our resources on social media ✔️ Using our posters and hosting community vox pops 📝 Writing to policymakers using our letter template Let’s…
"From #Kigali: At #IAS2025, the #HIV response rallies to face the crises" 📲 Check out @HIVpxresearch's post-conference roundup! avac.org/blog/ias2025-p…
Access to #SelfCare interventions empower individuals to take control of their own health 💪 Examples include: 🔹 Self-injectable contraceptives 🔹 Self-testing for HIV 🔹 HPV self-sampling 🔹 Self-monitoring of hypertension 🔹 Ovulation kits and pregnancy tests 🔗…
Congrès #IAS2025 : les Français très présents dans la recherche sur le VIH. lequotidiendumedecin.fr/actu-medicale/…
Congratulations to Timor-Leste! Timor-Leste has been certified malaria-free by @WHO, a major milestone built on years of leadership, investment and community-driven action. #DefeatMalaria Read more: theglobalfund.org/en/news/2025/2…
"Most people on ARVs stay on them — does our health system know that?" via @Bhekisisa_MG, #IAS2025 bhekisisa.org/health-news-so…
Why are They Leaving?… Factors Associated With Attrition After Testing... sciencedirect.com/science/articl…